SphynKx Therapeutics' Grant

SphynKx Therapeutics raised a round of funding on July 05, 2012. Investors include National Institute of General Medical Sciences.

SphynKx Therapeutics is a privately held biotechnology company based in Charlottesville, VA. We are focused on discovering, developing, and commercializing novel sphingosine kinase (SphK) inhibitors f…

Articles about SphynKx Therapeutics' Grant: